SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is experiencing significant momentum following recent international regulatory approvals for its Anktiva treatment and compelling updates from ongoing clinical trials, fueling widespread community optimism. The stock is seeing massive trading volume and a strong belief in an intensifying short squeeze, with many retail investors expressing conviction in the company's long-term potential to revolutionize cancer treatment.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following Madryn Asset Management's acquisition of a 91% stake, sparking widespread discussion about potential privatization or delisting to reduce operational costs. The community is sharply divided, with bulls anticipating a significant short squeeze fueled by the now extremely low public float. Conversely, skeptics caution against a "pump and dump" scenario and potential dilution or a lower buyout price as the company's long-term financials are scrutinized.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is gaining significant attention following its long-term data center leasing agreement with AMD, signaling a major strategic expansion into high-performance computing and AI infrastructure. The community is actively discussing this as a pivotal validation of Riot's strategy, with many anticipating substantial future growth and a strong competitive edge over peers.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending as its investor day revealed significantly raised 2026 revenue guidance and a surging backlog, reinforcing bullish outlooks for its autonomous defense and security solutions. Despite mixed community reactions to the presentation's delivery and short-term price fluctuations, investors are keenly focused on the company's strategic growth in the drone sector and the substantial capital raised, which many view as a strong long-term indicator.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending due to multiple analyst downgrades and heightened concerns over AI-driven competition, including new offerings from Apple, impacting the broader software sector. While many express fear that AI will significantly disrupt Adobe's established creative suite and subscription model, others view the stock as deeply oversold given its strong fundamentals, consistent growth, and historically low valuation, anticipating a rebound as AI integration evolves.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending amid community discussion around regulatory challenges from the NCAA's push for federal restrictions on college sports betting, coupled with recent reports of lower gaming revenues in key markets attributed to 'customer-friendly' outcomes and the rising influence of prediction markets. While some investors express frustration over competitive pressures and the stock's past performance, others view the current downturn as an overreaction, pointing to strong underlying user engagement, analyst upgrades, and new market expansions as catalysts for future growth.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is trending with notable share price volatility, driven by community discussions around significant insider selling pressures and upcoming lock-up expirations. Despite its strong product adoption and recent AI integrations, investor sentiment remains polarized between those viewing it as an undervalued opportunity and others expressing deep frustration over its post-IPO performance.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending due to its recent strategic partnership with World Liberty Financial and the anticipated launch of its Super App, which is set to boost its real-world utility in on-chain payroll and payments. The community is overwhelmingly bullish, frequently comparing ZBCN's ISO 20022 and MiCA compliance and expansion plans to early-stage XRP and XLM. Significant interest is also building around upcoming tokenomics updates and potential integrations with other major blockchains like Stellar and Ripple.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is drawing significant attention following the announcement of a new 200 million share buyback program and substantial European defense procurements, including Leopard 2 tanks powered by its MTU engines. The community expresses strong bullish sentiment, anticipating robust upcoming earnings and the game-changing potential of its Small Modular Reactor (SMR) technology.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is generating significant community discussion and anticipation around upcoming clinical data readouts, particularly the full Cohort 4 results for its atopic dermatitis program expected in January, alongside a presentation at a major healthcare conference. Investors are actively debating the potential for these data to validate its ITK inhibitor mechanism, close a perceived valuation gap with peers in the large atopic dermatitis market, and potentially pave the way for partnerships that could address financing needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LEXX  
$NVO $LLY $TEVA $MRK  
 
$LEXX coming to GLP-1 Market! 
 
“Our MTA partner is of great importance to us but is not our only business initiative. Lexaria has held a variety of discussions during 2025 – and expects this to intensify in 2026 – with a number of other pharmaceutical companies located in various jurisdictions around the world. DHT technology is not only being discussed within the GLP-1 drug sector, but also for other applications where Lexaria has completed previous investigatory work (e.g., for DHT-CBD for hypertension where we are ideally seeking to achieve strategic partner funding support for prospective future development activities of this Company asset), and even for brand-new drug sectors where DHT has never before been utilized. These discussions are being held with companies ranging in size from smaller regional companies up to and including some of the largest pharmaceutical companies in the world.”

Turbofueled

tokenredhead

Ricardo Joseph

Anonymous

Makingmillions192

StockTwits Web

Lexaria Bioscience Corp

Novo Nordisk A/S

Lilly(Eli) & Co

Teva- Pharmaceutical Industries Ltd. - ADR

Merck & Co Inc

 coming to GLP-1 Market! 
 
“Our MTA partner is of great importance to us but is not our only business initiative. Lexaria has held a variety of discussions during 2025 – and expects this to intensify in 2026 – with a number of other pharmaceutical companies located in various jurisdictions around the world. DHT technology is not only being discussed within the GLP-1 drug sector, but also for other applications where Lexaria has completed previous investigatory work (e.g., for DHT-CBD for hypertension where we are ideally seeking to achieve strategic partner funding support for prospective future development activities of this Company asset), and even for brand-new drug sectors where DHT has never before been utilized. These discussions are being held with companies ranging in size from smaller regional companies up to and including some of the largest pharmaceutical companies in the world.”